CN Patent
CN1871021B — 用gaba类似物的前药治疗或预防多动腿综合征
Assigned to XenoPort Inc · Expires 2010-07-28 · 16y expired
What this patent protects
本文公开了一种用γ-氨基丁酸(GABA)类似物前药和它的药物组合物治疗或预防人类多动腿综合征的方法,以及GABA类似物的前药的药物组合物在治疗或预防多动腿综合征中的用途。
USPTO Abstract
本文公开了一种用γ-氨基丁酸(GABA)类似物前药和它的药物组合物治疗或预防人类多动腿综合征的方法,以及GABA类似物的前药的药物组合物在治疗或预防多动腿综合征中的用途。
Drugs covered by this patent
- Horizant (GABAPENTIN ENACARBIL) · Azurity
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.